Skip to content

Clinical trials

Observational Carcinoma, Intraductal, Noninfiltrating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Phase: Observational Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20063
20086
20096
20104
20112
20132
20142
20151
20164
20172
20185
20192
20202
20211
20223
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Unknown status8
Recruiting7
Active, not recruiting4
Terminated1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic4
University of Nebraska3
Wake Forest University Health Sciences3
Dana-Farber Cancer Institute2
Ontario Clinical Oncology Group (OCOG)2
PreludeDx2
Yale University2
Atossa Therapeutics, Inc.1
Case Comprehensive Cancer Center1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating60
Breast Neoplasms42
Breast Carcinoma In Situ12
Carcinoma, Lobular5
Carcinoma, Ductal, Breast3
Neoplasms3
Precancerous Conditions3
Pain2
Anxiety Disorders1
Breast Diseases1

Trials

Showing 51 to 60 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.